Skip to content

The Effect of Esketamine Combined with Sufentanil Intravenous Patient-Controlled Analgesia on Postoperative Negative Emotions and Recovery Quality in Patients Undergoing Debridement and Skin Grafting

The Effect of Esketamine Combined with Sufentanil Intravenous Patient-Controlled Analgesia on Postoperative Negative Emotions and Recovery Quality in Patients Undergoing Debridement and Skin Grafting

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117306
Enrollment
Unknown
Registered
2026-01-22
Start date
2026-02-15
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn

Interventions

Experimental group ES group (esketamine and sufentanil):Esketamine combined with sufentanil
Control group S (sufentanil):Sufentanil alone

Sponsors

The First People’s Hospital of Lianyungang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients >=18 years old, BMI18-30kg/m^2; 2.ASA?-? grade, patients scheduled for elective scab resection and skin grafting surgery; 3.No history of mental illness or mental illness, not pregnant or lactating women; 4.The surgical site only involves the trunk and limbs, not the head, neck and perineum. The patient has no airway or organ damage, fractures, etc. 5.No clinical manifestations such as circulatory shock and dyspnea; 6.Receiving postoperative patient-controlled intravenous analgesia (PCIA); 7.No need for ICU admission or tracheal intubation after surgery; 8.Clearly understand and voluntarily participate in this study, and sign the informed consent form;

Exclusion criteria

Exclusion criteria: 1. Allergy to the investigational drug; 2. Unstable ischemic heart disease, severe pulmonary hypertension, poorly controlled or untreated hypertension (systolic/diastolic pressure over 180/100 mmHg); 3. Risk of increased intracranial or intraocular pressure; 4. Untreated or inadequately treated hyperthyroidism or history of epilepsy; 5. Chronic pain or long-term use of analgesics; 6. Need for mechanical ventilation during the perioperative period or presence of significant organ dysfunction; 7. Requirement for multiple surgeries during the study; 8. Refusal or inability to use a patient-controlled intravenous analgesia (PCIA) pump; 9. Preoperative 1-day Patient Health Questionnaire-9 (PHQ-9) score >= 15.

Design outcomes

Primary

MeasureTime frame
Postoperative anxiety and depression;

Secondary

MeasureTime frame
postoperative pain;Preoperative and postoperative anxiety scores;Postoperative recovery quality;Preoperative and postoperative depression scores;postoperative sleep quality;

Countries

China

Contacts

Public ContactRuidong Sun

The First People’s Hospital of Lianyungang

1165607261@qq.com+86 518 85605370

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026